WW International (WW), more commonly known as Weight Watchers, is fully embracing the popularity of GLP-1s and their impact on weight loss management with a new platform that integrates GLP-1 ...

WW International is a Sell due to persistent losses, negative cash flow, and lack of a competitive moat in weight management ...

WW International (NASDAQ:WW) has integrated its Weight Watchers Med+ offering with Eli Lilly’s (NYSE:LLY) LillyDirect ...

A redesigned Weight Watchers experience pairs GLP-1 prescriptions with personalized nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and ...

LillyDirect customers can now connect to Weight Watchers Med+ program, an integrated GLP-1 access and care model, driving greater weight loss results than medication aloneNEW YORK, June 04, 2026 ...

Weight Watchers announced a new weight loss program for people with type 2 diabetes, which it will provide through its employee wellness offering. The new program, called Weight Watchers for Diabetes, ...

Through expanded collaboration with Novo Nordisk, eligible Med+ members can now save up to $1,200 per year on Wegovy®, increasing affordable access to FDA-approved GLP-1 treatment leveraging Weight ...